Skip to content
LATEST
Health

Cannabinol (CBN) Linked to Potential Dependence and Immune Risks in Preclinical Study

Preclinical research suggests that the sleep aid ingredient cannabinol may cause physical dependence and immune system suppression, prompting calls for…

Cannabinol (CBN) Linked to Potential Dependence and Immune Risks in Preclinical Study

Recent preclinical research indicates that cannabinol (CBN), a common ingredient in over-the-counter sleep supplements, may induce physiological dependence and tolerance. Experiments on mice demonstrated that repeated exposure to the compound resulted in withdrawal symptoms and subjective effects comparable to those associated with THC.

Beyond dependence risks, the study identified potential immunosuppressive effects, suggesting that CBN may impair the body's ability to defend against bacterial infections. While these findings are limited to animal models, they highlight a significant gap in clinical data regarding the long-term safety and efficacy of CBN in human populations.

The widespread commercial availability of CBN products currently outpaces regulatory understanding of their pharmacological impact. Policymakers and health authorities face increasing pressure to evaluate whether existing safety standards for minor cannabinoids are sufficient to protect consumers from potential habit-forming properties and adverse health outcomes.

More stories

Latest news